P109: One-Day Brentuximab-Bendamustine (120mg/m2) every 21 days is a feasible and safe treatment for relapsed/refractory Hodgkin lymphomaHannah Moatti, Marie-Céleste Laroque,Loïc. Renaud,Odonchimeg Ravdan, Charlotte Schmidt-Hieber,Isabelle Madelaine,Roberta Di Blasi,Catherine Thieblemont,Pauline BriceHemaSphere(2022)引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要